Patent Expiry
CPIX: VIBATIV: recorded patent 7531623 expiry
January 1, 2027 · TELAVANCIN HYDROCHLORIDE. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- January 1, 2027
- Company
- CUMBERLAND PHARMACEUTICALS INC (CPIX)
- Drug
- TELAVANCIN HYDROCHLORIDE
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
VIBATIV: recorded patent 7531623 expiry
Orange Book application NDA022110, product 001, listed patent 7531623 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source
- Drug
- TELAVANCIN HYDROCHLORIDE